Cargando…
In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration
BACKGROUND: To establish the co-delivery liposomes of gefitinib (GFT) and curcumin (CUR) via oral administration with the goals of improving the synergistic effect and reducing acquired drug resistance. METHODS: We prepared liposomes (LPs) which can embed the anticancer compound GFT and CUR and inve...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735942/ https://www.ncbi.nlm.nih.gov/pubmed/33328741 http://dx.doi.org/10.2147/OTT.S276837 |